Logo image of RGS

REGIS CORP (RGS) Stock Fundamental Analysis

NASDAQ:RGS - Nasdaq - US7589322061 - Common Stock - Currency: USD

23.25  -0.21 (-0.9%)

Fundamental Rating

3

RGS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 71 industry peers in the Diversified Consumer Services industry. There are concerns on the financial health of RGS while its profitability can be described as average. RGS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year RGS was profitable.
RGS had a positive operating cash flow in the past year.
In the past 5 years RGS reported 4 times negative net income.
In the past 5 years RGS always reported negative operating cash flow.
RGS Yearly Net Income VS EBIT VS OCF VS FCFRGS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

RGS has a Return On Assets of 19.22%. This is amongst the best in the industry. RGS outperforms 95.77% of its industry peers.
RGS has a Return On Equity of 143.12%. This is amongst the best in the industry. RGS outperforms 100.00% of its industry peers.
RGS has a better Return On Invested Capital (3.51%) than 63.38% of its industry peers.
Industry RankSector Rank
ROA 19.22%
ROE 143.12%
ROIC 3.51%
ROA(3y)1.6%
ROA(5y)-3.87%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RGS Yearly ROA, ROE, ROICRGS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

1.3 Margins

RGS's Profit Margin of 49.34% is amongst the best of the industry. RGS outperforms 98.59% of its industry peers.
Looking at the Operating Margin, with a value of 9.15%, RGS is in the better half of the industry, outperforming 67.61% of the companies in the same industry.
RGS's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 101.72%, RGS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
RGS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.15%
PM (TTM) 49.34%
GM 101.73%
OM growth 3YN/A
OM growth 5Y92.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.74%
GM growth 5Y16.96%
RGS Yearly Profit, Operating, Gross MarginsRGS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so RGS is destroying value.
The number of shares outstanding for RGS remains at a similar level compared to 1 year ago.
Compared to 5 years ago, RGS has less shares outstanding
Compared to 1 year ago, RGS has an improved debt to assets ratio.
RGS Yearly Shares OutstandingRGS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
RGS Yearly Total Debt VS Total AssetsRGS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 0.42, we must say that RGS is in the distress zone and has some risk of bankruptcy.
RGS has a Altman-Z score (0.42) which is in line with its industry peers.
RGS has a debt to FCF ratio of 9.91. This is a negative value and a sign of low solvency as RGS would need 9.91 years to pay back of all of its debts.
RGS has a Debt to FCF ratio of 9.91. This is in the better half of the industry: RGS outperforms 61.97% of its industry peers.
A Debt/Equity ratio of 1.63 is on the high side and indicates that RGS has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.63, RGS is doing worse than 69.01% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.63
Debt/FCF 9.91
Altman-Z 0.42
ROIC/WACC0.28
WACC12.35%
RGS Yearly LT Debt VS Equity VS FCFRGS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 0.47 indicates that RGS may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.47, RGS is doing worse than 83.10% of the companies in the same industry.
RGS has a Quick Ratio of 0.47. This is a bad value and indicates that RGS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of RGS (0.47) is worse than 76.06% of its industry peers.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.47
RGS Yearly Current Assets VS Current LiabilitesRGS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2

3. Growth

3.1 Past

RGS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1934.03%, which is quite impressive.
RGS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 100.49% yearly.
The Revenue has decreased by -4.88% in the past year.
Measured over the past years, RGS shows a very negative growth in Revenue. The Revenue has been decreasing by -28.27% on average per year.
EPS 1Y (TTM)1934.03%
EPS 3YN/A
EPS 5Y100.49%
EPS Q2Q%108.41%
Revenue 1Y (TTM)-4.88%
Revenue growth 3Y-21%
Revenue growth 5Y-28.27%
Sales Q2Q%15.81%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-107.14%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-6.39%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RGS Yearly Revenue VS EstimatesRGS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
RGS Yearly EPS VS EstimatesRGS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 0.62, the valuation of RGS can be described as very cheap.
Based on the Price/Earnings ratio, RGS is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
RGS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.30.
RGS is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 0.62
Fwd PE N/A
RGS Price Earnings VS Forward Price EarningsRGS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, RGS is valued cheaply inside the industry as 83.10% of the companies are valued more expensively.
97.18% of the companies in the same industry are more expensive than RGS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.02
EV/EBITDA 7.18
RGS Per share dataRGS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40 60 80

4.3 Compensation for Growth

RGS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.01
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

RGS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

REGIS CORP

NASDAQ:RGS (7/8/2025, 8:00:01 PM)

23.25

-0.21 (-0.9%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)04-29 2025-04-29
Earnings (Next)08-26 2025-08-26/amc
Inst Owners32.4%
Inst Owner Change0%
Ins Owners10.8%
Ins Owner Change0.04%
Market Cap56.73M
Analysts80
Price TargetN/A
Short Float %4.55%
Short Ratio8.83
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 0.62
Fwd PE N/A
P/S 0.28
P/FCF 5.02
P/OCF 4.7
P/B 0.83
P/tB N/A
EV/EBITDA 7.18
EPS(TTM)37.35
EY160.65%
EPS(NY)-2.67
Fwd EYN/A
FCF(TTM)4.63
FCFY19.92%
OCF(TTM)4.95
OCFY21.29%
SpS81.6
BVpS28.13
TBVpS-49.83
PEG (NY)N/A
PEG (5Y)0.01
Profitability
Industry RankSector Rank
ROA 19.22%
ROE 143.12%
ROCE 4.44%
ROIC 3.51%
ROICexc 3.63%
ROICexgc 6.96%
OM 9.15%
PM (TTM) 49.34%
GM 101.73%
FCFM 5.68%
ROA(3y)1.6%
ROA(5y)-3.87%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y22.11%
ROICexc growth 3YN/A
ROICexc growth 5Y42.42%
OM growth 3YN/A
OM growth 5Y92.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.74%
GM growth 5Y16.96%
F-Score7
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 1.63
Debt/FCF 9.91
Debt/EBITDA 5.17
Cap/Depr 22.58%
Cap/Sales 0.39%
Interest Coverage 250
Cash Conversion 55.78%
Profit Quality 11.51%
Current Ratio 0.47
Quick Ratio 0.47
Altman-Z 0.42
F-Score7
WACC12.35%
ROIC/WACC0.28
Cap/Depr(3y)33.16%
Cap/Depr(5y)56.96%
Cap/Sales(3y)0.77%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1934.03%
EPS 3YN/A
EPS 5Y100.49%
EPS Q2Q%108.41%
EPS Next Y-107.14%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.88%
Revenue growth 3Y-21%
Revenue growth 5Y-28.27%
Sales Q2Q%15.81%
Revenue Next Year-6.39%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-9.36%
EBIT growth 3YN/A
EBIT growth 5Y38.21%
EBIT Next Year66.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y179.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y194.71%
OCF growth 3YN/A
OCF growth 5YN/A